Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Incorporating Drug Metabolism by the Human Gut Microbiome Into Personalized Medicine
NCT05065671Phase 1Completed
- Sponsor
- Rutgers University
- Start
- Feb 2022
- Primary completion
- Sep 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1 trial of tolcapone and duloxetine (2 arms), sponsored by Rutgers University. Primary endpoints: Area Under the Plasma Concentration versus Time Curve at 8 hours, Peak Plasma Concentration at 8 hours and 4 more. Started Feb 2022; status: completed.
02
Drugs
tolcaponeduloxetine
Beyond the preview
Go deeper on NCT05065671.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05065671.